Viewing Study NCT06544421



Ignite Creation Date: 2024-10-26 @ 3:37 PM
Last Modification Date: 2024-10-26 @ 3:37 PM
Study NCT ID: NCT06544421
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-08-06

Brief Title: The Impact of Chatbot-Assisted Nursing Education on Perceived Burden of Care and Caregiver Stress
Sponsor: None
Organization: None

Study Overview

Official Title: The Effect of Chatbot-Assisted Nursing Education on Perceived Care Burden and Caregiver Stress
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Caregivers play a key role in the provision of day-to-day care and the coordination of care services Caregivers of stroke patients use dysfunctional coping strategies to cope with the stressors and burden of care they encounter during this long caregiving process In this study it will be tried to improve the stress coping skills of caregivers by using an application with chatbot support based on the COM-B modelIn the study introductory information form stress coping styles scale depression anxiety stress DASS 21 and burden of care measurement tool will be used The study will be conducted in a randomized controlled manner Chatbot will be applied to the experimental group and the control group will be exposed to routine practice The study group will consist of individuals who care for those who are discharged home from Atatürk University stroke center Experiments and controls will be accessed by searching the hospital records The fact that nursing education is given through a chatbot and that the chatbot is designed according to a stress training model behavior change wheel reflects the originality of the study With this study caregivers are expected to be able to manage stress effectively by teaching them how to cope with stress
Detailed Description: gree relatives who care for the patients who receive 3-5 points from the Modified Rankin Scale will be discharged from the stroke center of the Neurology Clinic of Atatürk University Health Research and Application Center located in the city center of ErzurumWith the expectation of a 50 percent reduction in the rate of stressed patients in the intervention group and a 10 percent decrease in the control group it was decided to include 31 people in each group with 90 percent power and 5 percent type 1 error The sample calculation was calculated using the open epi version 301 web interfaceIt is expected that the implementation and reporting of the research will take 2 years Year 1 Preparation of chatbot and determination of experimental controls Implementation of training Collection of results and writing of the report in 1 year

The caregivers included in the experimental group will be told about the study and their written consent will be obtained Individuals in the experimental group will be asked to apply the data collection forms prepared before the use of the application is explained After the pre-test data is collected a chatbot-supported application will be installed on the caregivers in the experimental group In order for them to participate in the sessions and complete the trainings in the determined plan flow caregivers will be called by phone and reminders will be made and checked The sessions are expected to end in 4 weeks 8 sessions Gabrielli et al 2021A participant will be scheduled to finish the application within a maximum of 4 weeks No intervention will be applied to the control group they will be followed up within the scope of the routine follow-up and treatment protocol of the clinic The chatbot-supported application which will be prepared for stroke patient care providers has been prepared in line with the literature using the COM-B model according to the needs of caregivers The prepared training content was sent to the experts and the final shape was given by taking the opinions of the experts

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None